• Klann et al. (2017). CRISPRtextendashCas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome. Nature Biotechnology.
  • Wright, and Sanjana (2016). CRISPR Screens to Discover Functional Noncoding Elements. Trends in Genetics.
  • Sanjana (2016). Genome-scale CRISPR pooled screens. Analytical Biochemistry.
  • Thakore et al. (2016). Editing the epigenome: technologies for programmable transcription and epigenetic modulation. Nature Methods.
  • Thakore et al. (2015). Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nature Methods.
  • K√∂ferle et al. (2015). Brave new epigenomes: the dawn of epigenetic engineering. Genome Medicine.
  • Hilton et al. (2015). Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature Biotechnology.
  • Konermann et al. (2014). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature.
  • Gilbert et al. (2014). Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation. Cell.
  • Heller et al. (2014). Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors. Nature Neuroscience.
  • Voigt, and Reinberg (2013). Epigenome editing. Nature Biotechnology.
  • Maeder et al. (2013). Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nature Biotechnology.
  • Mendenhall et al. (2013). Locus-specific editing of histone modifications at endogenous enhancers. Nature Biotechnology.